Multiple clinical studies proved that SFRP4 is involved in the occurrence and development of T2DM, as elevated serum SFRP4 puts patients at three-folds higher risk of developing diabetes (10, 112–115). Here, SFRP4 is linked to type 2 diabetes mellitus.